Cargando…

Microglia display modest phagocytic capacity for extracellular tau oligomers

BACKGROUND: Abnormal misfolded tau protein is a driving force of neurofibrillary degeneration in Alzheimer’s disease. It has been shown that tau oligomers play a crucial role in the formation of intracellular neurofibrillary tangles. They are intermediates between soluble tau monomers and insoluble...

Descripción completa

Detalles Bibliográficos
Autores principales:	Majerova, Petra, Zilkova, Monika, Kazmerova, Zuzana, Kovac, Andrej, Paholikova, Kristina, Kovacech, Branislav, Zilka, Norbert, Novak, Michal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4172893/ https://www.ncbi.nlm.nih.gov/pubmed/25217135 http://dx.doi.org/10.1186/s12974-014-0161-z

Ejemplares similares

Truncated tau deregulates synaptic markers in rat model for human tauopathy
por: Jadhav, Santosh, et al.
Publicado: (2015)

First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model
por: Kontsekova, Eva, et al.
Publicado: (2014)

Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammation
por: Zilkova, Monika, et al.
Publicado: (2020)

Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease
por: Stozicka, Zuzana, et al.
Publicado: (2010)

Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer’s disease
por: Kontsekova, Eva, et al.
Publicado: (2014)

Therapeutic antibody targeting microtubule-binding domain prevents neuronal internalization of extracellular tau via masking neuron surface proteoglycans
por: Weisová, Petronela, et al.
Publicado: (2019)

Who fans the flames of Alzheimer's disease brains? Misfolded tau on the crossroad of neurodegenerative and inflammatory pathways
por: Zilka, Norbert, et al.
Publicado: (2012)

Enriched environment ameliorates propagation of tau pathology and improves cognition in rat model of tauopathy
por: Mate, Veronika, et al.
Publicado: (2022)

Evaluation of a novel immunoassay to detect p-tau Thr217 in the CSF to distinguish Alzheimer disease from other dementias
por: Hanes, Jozef, et al.
Publicado: (2020)

Tau Protein and Its Role in Blood–Brain Barrier Dysfunction
por: Michalicova, Alena, et al.
Publicado: (2020)

Phagocytosis of full-length Tau oligomers by Actin-remodeling of activated microglia
por: Das, Rashmi, et al.
Publicado: (2020)

p38 Inhibition Decreases Tau Toxicity in Microglia and Improves Their Phagocytic Function
por: Perea, Juan R., et al.
Publicado: (2022)

Ten Years of Tau-Targeted Immunotherapy: The Path Walked and the Roads Ahead
por: Novak, Petr, et al.
Publicado: (2018)

Determination of immunogenic proteins in biopharmaceuticals by UHPLC–MS amino acid analysis
por: Piestansky, Juraj, et al.
Publicado: (2019)

Novel Blood–Brain Barrier Shuttle Peptides Discovered through the Phage Display Method
por: Majerova, Petra, et al.
Publicado: (2020)

The Distance between N and C Termini of Tau and of FTDP-17 Mutants Is Modulated by Microtubule Interactions in Living Cells
por: Di Primio, Cristina, et al.
Publicado: (2017)

FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer’s disease
por: Novak, Petr, et al.
Publicado: (2018)

Characteristics of Tau Oligomers
por: Ren, Yan, et al.
Publicado: (2013)

Tau Oligomers Neurotoxicity
por: Niewiadomska, Grazyna, et al.
Publicado: (2021)

Phagocytic microglia in development: Are they what they eat?
por: VanRyzin, Jonathan W.
Publicado: (2021)

Hyperphosphorylation-Induced Tau Oligomers
por: Iqbal, Khalid, et al.
Publicado: (2013)

Phagocytic microglia and macrophages in brain injury and repair
por: Yu, Fang, et al.
Publicado: (2022)

Phagocytic astrocytes: Emerging from the shadows of microglia
por: Konishi, Hiroyuki, et al.
Publicado: (2022)

Profiling of Amino Acids in Urine Samples of Patients Suffering from Inflammatory Bowel Disease by Capillary Electrophoresis-Mass Spectrometry
por: Piestansky, Juraj, et al.
Publicado: (2019)

Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern
por: Kovacech, Branislav, et al.
Publicado: (2022)

Phagocytic glioblastoma-associated microglia and macrophages populate invading pseudopalisades
por: Saavedra-López, Elena, et al.
Publicado: (2019)

Oligomer Formation of Tau Protein Hyperphosphorylated in Cells
por: Tepper, Katharina, et al.
Publicado: (2014)

Tau oligomers in cerebrospinal fluid in Alzheimer's disease
por: Sengupta, Urmi, et al.
Publicado: (2017)

Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage
por: Shafiei, Scott S., et al.
Publicado: (2017)

Separation of Isomeric Tau Phosphopeptides from Alzheimer’s Disease Brain by Cyclic Ion Mobility Mass Spectrometry
por: Kováč, Andrej, et al.
Publicado: (2023)

Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer’s disease? From preclinical studies to the clinical trials
por: Basheer, Neha, et al.
Publicado: (2023)

Microglia degrade Tau oligomers deposit via purinergic P2Y12-associated podosome and filopodia formation and induce chemotaxis
por: Chinnathambi, Subashchandrabose, et al.
Publicado: (2023)

Galectin-3 (MAC-2) Controls Microglia Phenotype Whether Amoeboid and Phagocytic or Branched and Non-phagocytic by Regulating the Cytoskeleton
por: Reichert, Fanny, et al.
Publicado: (2019)

Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau
por: Lasagna-Reeves, Cristian A., et al.
Publicado: (2012)

Rescue from tau-induced neuronal dysfunction produces insoluble tau oligomers
por: Cowan, Catherine M., et al.
Publicado: (2015)

The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer’s Disease (AD)
por: Mroczko, Barbara, et al.
Publicado: (2019)

p27(kip1) Modulates the Morphology and Phagocytic Activity of Microglia
por: Beeken, Jolien, et al.
Publicado: (2022)

Tau Oligomers: The Toxic Player at Synapses in Alzheimer’s Disease
por: Guerrero-Muñoz, Marcos J., et al.
Publicado: (2015)

Preparation of stable tau oligomers for cellular and biochemical studies
por: Karikari, Thomas K., et al.
Publicado: (2019)

Oligomer Diversity during the Aggregation of the Repeat Region of Tau
por: Kjaergaard, Magnus, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ck5thh7vvttphtd71dgmeie0m2